GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

Clinical trial NCT07314684 · RECRUITING

Trial details

NCT number: NCT07314684
Sponsor: Federico II University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2025-09-08
Primary completion: 2027-03-08
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.